COVID-19 Telemedicine White Paper 
Healthcare IT News - Telehealth
FEBRUARY 9, 2021
A report released Tuesday by Foley & Lardner LLP found that the COVID-19 pandemic compelled state and federal policymakers to remove restrictions on and expand reimbursement for telehealth and virtual care at unprecedented rates. "The public health emergency did not create the telemedicine industry. WHY IT MATTERS.
Healthcare IT Today
NOVEMBER 3, 2022
Download our white paper, “ Leading enterprise content strategy with health information management: An executive guide for acquiring a document management and imaging platform.”. Beyond COVID-19: Thriving in the Evolving Healthcare Technology Landscape. . Beyond COVID-19: Data considerations when switching your EMR.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Healthcare It News
NOVEMBER 2, 2021
The healthcare industry continues to fight the COVID-19 pandemic with innovation and grit. Kate Huey, who leads IBM’s Global Healthcare Transformation team, explains how COVID-19 has amplified: • Existing gaps in healthcare delivery. Many organizations pivoted to allow nonessential workers to work remotely.
Healthcare IT News - Telehealth
DECEMBER 1, 2020
The National Governors Association released a white paper this week examining state policies around telehealth and outlining key considerations for governors to assess the potential implications of said policies going forward. THE LARGER TREND. ON THE RECORD. " Kat Jercich is senior editor of Healthcare IT News.
Healthcare IT News - Telehealth
OCTOBER 29, 2020
Drug Enforcement Agency to implement a telemedicine special registration that would allow providers to remotely prescribe controlled substances. "In the six months since COVID-19 brought the nation to a standstill, the opioid epidemic has taken a sharp turn for the worse," the groups wrote. ON THE RECORD.
Healthcare IT Today
JANUARY 12, 2023
Most health IT companies are held to a low standard of evidence of value and proof of ROI through marketing white papers and quantification that is not robust or systematically evaluated, rather than being required to demonstrate value through scientific peer review and journal publication.
Expert insights. Personalized for you.
217 
Let's personalize your content